NCT06511739View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

May 27, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

October 1, 2025

Conditions
Non-segmental Vitiligo
Interventions
DRUG

SYHX1901

SYHX1901 tablet

DRUG

placebo

Oral tablet

Trial Locations (1)

Unknown

RECRUITING

Clinical Trials Information Group, Shijiazhuang

Sponsors
All Listed Sponsors
collaborator

Zhongqi Pharmaceutical Technology (Shijiazhuang) Co. Ltd.

UNKNOWN

lead

CSPC Ouyi Pharmaceutical Co., Ltd.

INDUSTRY